SANAI HEALTH INDUSTRY GROUP COMPANY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.03 HKD | 0.00% |
|
+3.45% | -53.12% |
| Sales 2021 | 67.61M 9.33M 73.12M | Sales 2022 | 176M 24.28M 190M | Capitalization | 226M 31.17M 244M |
|---|---|---|---|---|---|
| Net income 2021 | 9M 1.24M 9.73M | Net income 2022 | 29M 4M 31.36M | EV / Sales 2021 | 4.37 x |
| Net cash position 2021 | 16.8M 2.32M 18.17M | Net Debt 2022 | 49.03M 6.77M 53.03M | EV / Sales 2022 | 1.56 x |
| P/E ratio 2021 |
34.6
x | P/E ratio 2022 |
7.9
x | Employees | 68 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 72.31% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | +3.45% | ||
| Current month | -25.00% | ||
| 1 month | -33.33% | ||
| 3 months | -38.78% | ||
| 6 months | -48.28% | ||
| Current year | -53.12% |
1 week
0.03
0.03
1 month
0.030.05
Current year
0.030.07
1 year
0.030.09
3 years
0.030.28
5 years
0.030.42
10 years
0.030.80
| Managers | Title | Age | Since |
|---|---|---|---|
Hao She
BRD | Director/Board Member | 41 | 19-11-10 |
Yuen Shan Li
SEC | Corporate Secretary | 43 | 20-04-08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rong Qing Zhang
BRD | Director/Board Member | 67 | 17-06-15 |
Yi Zhun Zhu
BRD | Director/Board Member | 58 | 20-12-30 |
Cheng Qing Chen
BRD | Director/Board Member | 46 | 17-02-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 0.03 | 0.00% | 22,500 |
| 24-04-22 | 0.03 | +7.14% | 910,000 |
| 24-04-19 | 0.028 | -6.67% | 2,405,000 |
| 24-04-18 | 0.03 | 0.00% | 4,250,000 |
| 24-04-17 | 0.03 | +3.45% | 1,132,500 |
Delayed Quote Hong Kong S.E., April 23, 2024 at 04:09 am EDT
More quotes
Sanai Health Industry Group Company Limited is an investment holding company principally engaged in the general trading business and pharmaceutical products business. The Company operates its business through three segments. The Pharmaceutical Products segment mainly engages in the development, manufacturing, marketing and sales of pharmaceutical products, sales of pharmaceutical related software and provision of consultancy services. The Finance Leasing segment mainly engages in the provision of finance leasing services. The Other General Trading segment engages in the distribution of fitness equipment, electric appliances and other goods for general trading.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -53.12% | 12.29M | |
| +27.92% | 659B | |
| +27.68% | 557B | |
| -4.59% | 359B | |
| +16.38% | 322B | |
| +9.39% | 297B | |
| +6.30% | 215B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.58% | 149B |
- Stock Market
- Equities
- 1889 Stock
